6,374 press releases indexed under healthcare.
Sixty-four dentists complete inaugural two-day implant course with Dr. Timothy Kosinski to earn 12 hours of CE
First case of its kind at Nicklaus Children's Hospital and among only a few in the U.S. MIAMI, Sept. 1, 2026 /PRNewswire/ -- Nicklaus Children's Hospital Helen & Jacob Shaham Cancer & Blood Disorders Institute has successfully accomplished a bone marrow transplant on a 2-year-old girl...
RAPPERSWIL, SWITZERLAND - September 1, 2026 ( NEWMEDIAWIRE ) - Neovii Pharmaceuticals AG today announced the appointment of Duncan Ferguson as Chief Commercial Officer (CCO) , effective 1 September 2026. Ferguson joins the company at a pivotal stage as Neovii accelerates the global expansion of its transplantation franchise and advances its strategic growth initiatives in immune-mediated diseases. Duncan brings nearly three decades of global commercial leadership experience spanning specialty pharmaceuticals, rare diseases, immunology, oncology and neuroscience. Throughout his career, he has built and scaled international commercial organizations, led successful market expansion strategies, and supported the launch and growth of innovative therapies across multiple regions. Most recently,
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in September:
SAN DIEGO, September 01, 2026--Styx Biotechnologies, Inc., a San Diego-based biotechnology company developing next-generation antibody-drug conjugates (ADCs) for solid tumors, today announced a strategic agreement with ZoeNCure Therapeutics Pvt. Ltd. to accelerate selected Styx ADC programs toward first-in-human clinical studies.
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
SAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases, today announced that it will participate in the Cantor Global Healthcare Conference, being held September 9-11 in New York, NY. Management will participate in a fireside chat on Thursday, September 10, 2026 at 3:20 p.m. EDT.
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that it will participate in the upcoming investor conferences:
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that it will participate in the Wells Fargo 21st Annual Healthcare Conference, taking place September 8-10, 2026, in Boston.
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA) (“Aura” or the “Company”), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for patients with ocular cancers, today announced that inducement equity awards (collectively, “Inducement Awards”) were granted to Erica Kratz, Ph.D., Aura’s new Chief Regulatory and Quality Officer, Susan Abu-Absi, Ph.D., Aura’s new Chief Operating Officer, and Julie Person, Aura’s new Chief People Officer, each on September 1, 2026 (the “Grant Date”). The Inducement Awards were approved by the Compensation Committee of the Board of Directors of the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
The article reviews how dentures and implant-based restorations support comfort, stability, and long-term jawbone health for patients missing teeth. ROCHESTER, N.Y., Sept. 1, 2026 /PRNewswire/ -- What options are available today for patients who need a full mouth replacement? According to...
AZ Blue Health Choice, AZ Langar on Wheels and Zeihan ProHealth partner to provide essential resources directly to people in need. PHOENIX, Sept. 1, 2026 /PRNewswire/ -- Thousands of hot meals, health screenings and essential supplies are reaching people experiencing homelessness in...